about
Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancerThe dimerization domain of SOX9 is required for transcription activation of a chondrocyte-specific chromatin DNA templateRAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibitionSOX9, through interaction with microphthalmia-associated transcription factor (MITF) and OTX2, regulates BEST1 expression in the retinal pigment epitheliumDirect interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Müllerian hormone geneA new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen geneCampomelic dysplasia translocation breakpoints are scattered over 1 Mb proximal to SOX9: evidence for an extended control region.SOX9 interacts with a component of the human thyroid hormone receptor-associated protein complex.Deletion of long-range regulatory elements upstream of SOX9 causes campomelic dysplasiaExpression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitroBMP receptor signaling is required for postnatal maintenance of articular cartilageA pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturationThe multifaceted role of the vasculature in endochondral fracture repairCell sources for the regeneration of articular cartilage: the past, the horizon and the futureFat-Dachsous signaling coordinates cartilage differentiation and polarity during craniofacial developmentRoles of microRNA and signaling pathway in osteoarthritis pathogenesisComplete sequence of the 23-kilobase human COL9A3 gene. Detection of Gly-X-Y triplet deletions that represent neutral variantsCompound effects of point mutations causing campomelic dysplasia/autosomal sex reversal upon SOX9 structure, nuclear transport, DNA binding, and transcriptional activationA new long form of c-Maf cooperates with Sox9 to activate the type II collagen geneRegulation of human COL9A1 gene expression. Activation of the proximal promoter region by SOX9BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1Hypoxia promotes the differentiated human articular chondrocyte phenotype through SOX9-dependent and -independent pathwaysRole of SOX9 in the Etiology of Pierre-Robin SyndromeSox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve developmentBMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formationA zinc finger transcription factor, alphaA-crystallin binding protein 1, is a negative regulator of the chondrocyte-specific enhancer of the alpha1(II) collagen geneMouse Snail family transcription repressors regulate chondrocyte, extracellular matrix, type II collagen, and aggrecanMint represses transactivation of the type II collagen gene enhancer through interaction with alpha A-crystallin-binding protein 1Distribution of the transcription factors Sox9, AP-2, and [delta]EF1 in adult murine articular and meniscal cartilage and growth plateDisrupted expression of matrix genes in the growth plate of the mouse cartilage matrix deficiency (cmd) mutantIdiopathic weight reduction in mice deficient in the high-mobility-group transcription factor Sox8Arid5a cooperates with Sox9 to stimulate chondrocyte-specific transcriptionTranscriptional Co-activators CREB-binding protein/p300 increase chondrocyte Cd-rap gene expression by multiple mechanisms including sequestration of the repressor CCAAT/enhancer-binding proteinThe chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bonesThe transcription factor SOX9 regulates cell cycle and differentiation genes in chondrocytic CFK2 cellsCooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilagep38 MAPK mediated in compressive stress-induced chondrogenesis of rat bone marrow MSCs in 3D alginate scaffoldsEgr-1 inhibits the expression of extracellular matrix genes in chondrocytes by TNFalpha-induced MEK/ERK signallingIdentification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2(XI) collagen geneExpression of transcription factor Sox9 in rat L6 myoblastic cells
P2860
Q22254066-AC832C6C-94DA-47A1-BBE0-BF5CCF233F59Q24313870-AC675D01-0B12-4757-971A-E8C4737FFCB2Q24316899-4F4B6B05-0A62-4E9F-B30C-66E54E7E2982Q24317482-CEB4C9EB-0D40-475D-80CD-EC2A51E84D78Q24522795-B9A8EE03-E195-4BA0-B866-3DF79A463051Q24533335-DA0784DF-F0E4-4C86-879B-77E92D0FBB7CQ24540293-A21E82FB-FB27-4CDA-A806-7E7672F26870Q24540356-F2C948E5-AAA1-4255-979D-8467FCE320A6Q24656897-3311EA6D-CC99-4166-8705-87D0899E1C1AQ24682147-184B2D8F-F115-449A-AF82-511AC11B2A2EQ24801945-80B2C05E-0C14-4B14-B490-50852E4371A2Q26995910-32C0B440-DEC6-4CE5-9F34-301B0162E5EAQ27013693-230C5B02-AB2F-4C05-9C60-A7401B219984Q27023782-49EDC3A6-7E69-46FE-B6CA-E330645D6FF9Q27312231-FF5FADF1-EFB5-489E-BF94-BDFFB18CCC49Q28069429-2FCF0F1A-8A55-4D7A-BF36-E93EB9A89913Q28140890-63F860C7-317F-4F9E-B320-EE71DC776B34Q28185681-B2E9C340-616A-45D4-863A-EE428E4C30A2Q28207757-8D27CCD2-5AE2-4035-B71F-E6742A91164DQ28210665-F368FF82-F7F0-43E5-BA10-2D7871F52179Q28211867-802C5FD9-5C7B-49E6-B5B8-88A3871EE338Q28260898-F607308E-C3CB-4C99-8CEE-A419F69A2603Q28293925-C0771545-6D36-4D23-AACA-7B2874253C33Q28504526-212FEA68-C27D-4E6E-A69F-BFC0AC5D2610Q28507269-13102D16-AE51-4A7E-85AB-254159D1F4C8Q28507335-55CEC836-EE22-45A6-BAE0-A6EF256D5958Q28507492-8CD42E28-A828-427B-9F26-3A115E73B424Q28509791-01803FEC-DD25-4ACE-A110-1BC5B1637302Q28511841-34DF38B1-1658-4A81-B411-18AC32C0BD57Q28512090-676DE5EE-F131-4042-AABC-94C3D9D0EDFFQ28512330-6C6BAA5E-F5B6-48E1-86B7-5F9F26FC5118Q28513326-5D663807-C95E-48C6-89F9-66497C49D086Q28565082-6187003F-1CA4-4FC7-B02A-C7E2A2723133Q28566665-20BD3EE7-759F-43C2-B6CA-BD9027665225Q28570025-AA13B24D-79C7-4608-85E5-3B319F127692Q28571441-933DFA02-F560-4124-814A-6180E800C07DQ28572942-E6C1647B-CF3C-4C04-94D3-78315C5E411BQ28574613-192A42E5-5E45-4A65-A4EB-BAC751DE1D0BQ28577764-E51A05D9-F07C-42CE-B3B5-CE93B06E3B7CQ28579961-492E3EF3-0B9C-41E6-B776-0E4F97E2FBB3
P2860
description
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
articolo scientifico
@it
artículu científicu espublizáu en 1997
@ast
im Juni 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1997/06/01)
@sk
vědecký článek publikovaný v roce 1997
@cs
wetenschappelijk artikel (gepubliceerd op 1997/06/01)
@nl
наукова стаття, опублікована в червні 1997
@uk
name
SOX9 directly regulates the type-II collagen gene
@ast
SOX9 directly regulates the type-II collagen gene
@en
SOX9 directly regulates the type-II collagen gene
@nl
type
label
SOX9 directly regulates the type-II collagen gene
@ast
SOX9 directly regulates the type-II collagen gene
@en
SOX9 directly regulates the type-II collagen gene
@nl
prefLabel
SOX9 directly regulates the type-II collagen gene
@ast
SOX9 directly regulates the type-II collagen gene
@en
SOX9 directly regulates the type-II collagen gene
@nl
P2093
P2860
P3181
P356
P1433
P1476
SOX9 directly regulates the type-II collagen gene
@en
P2093
D. M. Bell
K. K. Leung
K. S. Cheah
K. W. Ling
M. H. Sham
S. C. Wheatley
P2860
P2888
P304
P3181
P356
10.1038/NG0697-174
P407
P577
1997-06-01T00:00:00Z